CVRx (CVRX) Liabilities and Shareholders Equity (2020 - 2026)

CVRx's (CVRX) quarterly Liabilities and Shareholders Equity came in at $99.7 million in Q1 2026, down 23.04% year-on-year from $129.6 million in Q1 2025, and down 4.83% quarter-over-quarter from $104.8 million in Q4 2025.

CVRx (CVRX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

CVRx's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $99.7 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 23.04% year-over-year to $99.7 million in Q1 2026; TTM through Mar 2026 was $435.4 million, a 10.53% decrease from a year earlier, with the FY2025 full-year figure at $104.8 million, down 21.45% from the prior year.
  • Liabilities and Shareholders Equity retreated to $99.7 million in Q1 2026 per CVRX's latest filing, from $104.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $144.4 million in Q1 2022 and bottomed at $96.0 million in Q2 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $119.6 million (2025), against an average of $118.7 million.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 143.43% in 2022; the steepest drop was 30.34% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $124.9 million in 2022, then retreated by 7.77% to $115.2 million in 2023, then grew by 15.78% to $133.4 million in 2024, then slipped by 21.45% to $104.8 million in 2025, then retreated by 4.83% to $99.7 million in 2026.
  • Per Business Quant, the three latest CVRX Liabilities and Shareholders Equity figures stand at $99.7 million (Q1 2026), $104.8 million (Q4 2025), and $111.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 CVRx 128.88 Mn 56.58 Mn 12.88 Mn 99.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 99.73 Mn
Dec 31, 2025 104.79 Mn
Sep 30, 2025 111.33 Mn
Jun 30, 2025 119.56 Mn
Mar 31, 2025 129.59 Mn
Dec 31, 2024 133.41 Mn
Sep 30, 2024 127.67 Mn
Jun 30, 2024 95.98 Mn
Mar 31, 2024 106.17 Mn
Dec 31, 2023 115.23 Mn
Sep 30, 2023 106.40 Mn
Jun 30, 2023 114.97 Mn
Mar 31, 2023 122.69 Mn
Dec 31, 2022 124.94 Mn
Sep 30, 2022 126.58 Mn
Jun 30, 2022 134.04 Mn
Mar 31, 2022 144.41 Mn
Dec 31, 2021 152.55 Mn
Sep 30, 2021 181.71 Mn
Jun 30, 2021 55.06 Mn